1 / 6
Laboratory Research Material
CJC-1295 + GHRP-2
10 mg per vial · Lyophilized powder
Laboratory Research Material
CJC-1295 + GHRP-2 10 mg per vial
Original price was: $99.99.$79.99Current price is: $79.99.
- Blend composition
-
Compound Per vial CJC-1295 5 mg GHRP-2 5 mg Total per vial 10 mg - Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- 2 business daysEstimated transitFree
shipping On orders $199+ 
2Day Weekday dispatch · 4 p.m. ET cutoff
Out of stock
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
CJC-1295 + GHRP-2 blend
Buy CJC-1295 + GHRP-2 blend with 5 mg of each peptide and 10 mg total labeled material per vial. This laboratory research product is supplied as lyophilized powder in one boxed 3 mL vial. The CJC component is CJC-1295 with DAC.
- CJC-1295 DAC: 5 mg
- GHRP-2: 5 mg
- Total blend: 10 mg per vial
Choose by the full composition
GHRP-2 distinguishes this mixture from CJC blends containing Ipamorelin or GHRP-6. If the experiment requires a single component, GHRP-2 5 mg is listed separately. The CJC-1295 NO DAC + Ipamorelin blend is a different two-component formulation.
This blend uses the DAC-bearing CJC-1295 form, reference CAS 446262-90-4. It differs from a NO DAC blend even when the labeled milligram amounts are the same. Match the actual peptide and its modification when comparing laboratory methods.
GHRP-2 and GRF in laboratory studies
Cheng and colleagues compared GHRP-2 with GHRP-6 in primary rat pituitary cells. Both interacted with GRF to increase growth-hormone release. The cells became desensitized to the GHRP compounds but not to GRF, and antagonist results helped distinguish their signaling pathways.
That experiment used defined compounds and cell conditions. It does not establish the activity of this finished 5 mg + 5 mg blend. Likewise, the albumin-conjugated CJC development work concerns a specifically modified construct, not every product carrying the CJC name.
Check each component’s documentation
Open Documents for the available product files and check the applicable lot report for its analytical methods. Look for the identity and measured amount of each named component; a combined result or total powder weight is not automatically a component-specific assay.
The composition above states labeled amounts. A two-peptide mixture has no single peptide sequence or molecular weight for the whole blend. Use component-specific records for molar calculations, and handling instructions applicable to the complete formulation. The vial capacity is a container specification, not an included liquid volume.
Additional information
| CAS No. | CJC-1295 DAC: 446262-90-4, GHRP-2: 158861-67-7 |
|---|---|
| Purity | ≥99% |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Applications | Growth hormone secretion studies, lean mass research, aging research |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.